-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today, Neuron23 announced the completion of a $100 million Series C financing
LRRK2 is a multi-protein domain complex protein found in neurons and other tissues and cell types throughout the body
Founded in 2018, Neuron23 is committed to harnessing the latest advances in human genetics, combined with cutting-edge AI-powered drug discovery and biomarker platforms, to develop innovative treatments for serious diseases
References:
[1] Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease.
Note: The original text has been deleted